Clinical Trials Logo

Clinical Trial Summary

Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children`s Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission). These values will be primarily analysed for their variability and their association with arterial hypotension. Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm. Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine. Copeptin`s predictive value for patients` outcome will be analysed as secondary outcome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03320967
Study type Observational
Source University Children's Hospital, Zurich
Contact
Status Completed
Phase
Start date December 4, 2017
Completion date June 30, 2019